The Relationship Between Serum Albumin Level and Nutritional Parameters with Mortality Rate, For Icu-Covid-19 Patients at Hazem Mebaireek General Hospital (HMGH), State of Qatar (March to September / 2020) by Al-Saadi, Reem et al.
Food Science and Quality Management                                                                                                                                             www.iiste.org 




The Relationship Between Serum Albumin Level and Nutritional 
Parameters with Mortality Rate, For Icu-Covid-19 Patients at 
Hazem Mebaireek General Hospital (HMGH), State of Qatar 
(March to September / 2020) 
 
Reem Al-Saadi      Noora Aljaffali      Anwar Qudaisat       Jadulluh Al-ghazo* 
Department of Dietetics - Hazem Mebaireek General Hospital (HMGH), Hamad Medical Corporation, Qatar 
 
Abstract 
There is limited information available describing the clinical and epidemiological features of COVID-19 patients 
at (HMGH) in Qatar, also there is lack of reporting about temporal association of Malnutrition and severity of 
COVID-19. This study was aimed to describe the relationship between serum albumin levels and certain 
nutritional parameter with mortality rate for ICU-COVID-19 patients. The study was conducted retrospectively 
on a group of adult patients, who were admitted to ICU at HMGH, from 01/04/ 2020 to 30/09/ 2020, who’s 
discharged from the hospital, whether recovered or expired, if they met the following inclusion criteria: ICU 
patients, ≥ 18 years of age, laboratory confirmed positive of COVID-19. Data of ICU-COVID-19 patients at 
HMGH will be extracted from electronic medical record (EMR). Total of 1059 patients, among them 78 (7.4%) 
patients were females and 981(92.6%) of them were males. Comparing with nationality 93(8.78%) patients were 
Qatari and 966(91.21%) were non-Qatari, 951 (89.8%) was survived & 108 (10.2%) were non survived, 
furthermore 12 (11.1 %) patients from the non-survived patients were Qatari & 96 (88.9 %) were non-Qatari. In 
the results it found that 136 (12.8%) of patients had Hyperlipidemia, 75 (7.1%) had obesity, 577 (54.5%) with 
diabetes, 513 (48.41%) with hypertension, & 129 (12.2%) had chronic lung disease. 581 patients had albumin 
value below 35 gm/L on admission and 768 had below 35 gm/L before discharge. 478 patients had albumin level 
above 35 gm/L on admission and 291 patients had above 35 gm/L albumin level before discharge. Among non-
survived patients who 108 (100%) of them had low serum albumin levels before death and 80 (74.1%) of them 
had below 35 gm/L albumin and 28 (25.9%) patients had 35 gm/L and above albumin levels on admission. In 
Qatar there were adequate implementation of interventions, protections & management to face COVID-19 
prevention.  Our study concluded that male patients & hypoalbuminemia were significantly risk of mortality 
associated with COVID-19. 
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Introduction 
COVID-19 consider as a new strain of Coronavirus, which start in Wuhan China in December 2019, and now 
become pandemic across the globe. The mortality rate of this virus over the world 3.4-4%, which make more 
severe compared with flu, The elderly who have co-morbidity are succumbing more to the COVID-19, People 
with mild symptoms usually recover within 3 to7 days, while those with previously have sever diseases take 
weeks to recover, the percentage rate of recovery for COVID-19 is expected to hit 90% (WHO, 2020) (1, 2). 
The COVID-19 disease in Qatar is part of the worldwide pandemic of corona virus disease 2019, according 
to the official reporting of ministry of public health (MOPH) the first confirmed case in Qatar was on 27 
February 2020, relative to its population, Qatar ranks the highest number of confirmed cases compared to other 
countries of the world, and comes the second country after Saudi Arabia in the number of confirmed cases in 
compared to other middle east countries, The number of deaths in Qatar has been low, related to the reported of 
confirmed cases (3). 
The mortality rate in Qatar based on governmental report and those from Johns Hopkins University is 0.3%, 
which may be to the country's adequate healthcare system and the fact of most of residents are young and 
healthy, The State of Qatar early has taken all precautionary measures to prevent the spread of COVID-19, These 
precautionary measures can be changed based on the latest guidance of MOPH and Word health organization 
(WHO) regarding to the spread of COVID-19 (4). 
COVID-19 has heterogeneous symptoms, many patients can show a wide array of symptoms while others 
remain carrier without symptomatic, most symptomatic patients vary from mild flu-like manifestations such as 
dry cough, myalgia, phlegm or diarrhea, to severe pneumonia or acute respiratory distress syndrome (ARDS), 
The exact pathobiology for severe and critically ill patients is still not clear (5). 
Generally, the most of positive patients with COVID-19 have symptoms of respiratory infection, with 
mortality rate 1.4–4%. The death in some cases that developed to critical illness may be due to massive alveolar 
damage and progressive respiratory failure, little is known regarding to the clinical markers for the ICU patients 
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with covid-19 (6). 
According to many studies, hypoalbuminemia may play a central role in the progression of symptoms from 
mild to severe COVID-19 especially those have malnutrition, and role in mortality rate across numerous clinical 
cases (7). Although the human serum albumin (HSA) has an antioxidant property, however its behavior and its 
relationship to the mortality rate in COVID-19 patients have not yet been studied (8). 
The pathophysiology for hypoalbuminemia in certain co-morbidities (such as pancreatitis, burn, infection, 
trauma, and organ dysfunction) is secondary result, to increased capillary permeability, decreased protein 
synthesis, decreased half-life of serum albumin, increased volume of distribution, decreased serum albumin total 
mass, and increase expression of vascular endothelial growth factor, it has been supposed that, the 
pathophysiology for hypoalbuminemia is assassinated with hallmark of severe COVID-19 (9). 
Human serum albumin level (HSAL) widely used in clinical practice, it reflects nutritional status and 
inflammatory response, which are related to outcomes of cancer treatment, and inflammatory diseases. Previous 
studies also found that HSAL was significantly lower in patients with severe COVID-19 (10). 
In this study, we will hypothesize that, serum albumin levels, BMI with certain nutritional parameters (Vit 
D, Vit B12, HbA1c and Cholesterol) is significant at admission, which might reflect the severity of systemic 
inflammation, and this can serve as a predictive factor for COVID-19 outcomes. Our study will lead to the 
hypothesis that, lower HSAL may be used to identify patients at high risk of death in diagnosed patients. 
According to the study conducted by Jiaofeng Huang, May 2020, the result showed that hypoalbuminemia 
is associated with the outcome of COVID 19. Also, there is an inverse relatio‐ nship between the level of 
albumin and increase the risk of death in COVID 19 patients (9).‐  
For Roberto de la Rica study conducted in Spain, it founds that Albumin might be of importance because of 
its association with disease severity in patients infected with  
COVID-19 (5). 
The objectives of the current study are: 
1.To determine the relationship between the serum albumin level and nutritional parameters, with mortality rate 
of ICU-COVID-19 patients through admission period in ICU. 
2. To compare the outcome of patients who have nutritional deficiencies with those patients without nutritional 
deficiencies through the admission period in ICU. 
 
Study Methodology 
The methodology adopted by the investigator is “quantitative Retrospective Data cohort study”. The data was 
extracted from EMR after getting approval from the medical record department, all COVID-19 adult patients 
who were admitted to ICU at HMGH from 01/04/2020 to 30/09/2020, who’s discharge from the hospital whether 
recovered or expired the researcher is assuming that the estimated sample size is 1000. 
 
Study Population. 
The study, will be conducted retrospectively on a group of adult patients, with COVID-19 positive who were 
admitted to ICU at HMGH State of Qatar at (01/04-30/09/ 2020), whose discharged from the hospital whether 
recovered or expired, if they met the following inclusion criteria: ICU patients, ≥ 18 years of age, laboratory-
confirmed diagnosis of COVID-19, through the admission period, & they will not be followed after discharged 
from ICU. Also, the patients who were admitted to ICU with COVID-19 positive & not discharged through the 
study period will be excluded. 
 
Data Collection & Confidentiality 
Data was extracted from the Electronic medical record, data collection by reviewing the patient file 
electronically and confidentiality will be maintained. In our data collection sheet, we removed hospital number, 
names, and any other identifiers to protect patient confidentiality. We replaced the Health Card number with 
Serial number. Only the investigators have the access to study related files and the data will be documented in 
Excel file. The principal investigator and 3 co-investigators collected the data from the Cerner with the help of 
medical record. any link between the code and identifier was deleted after data collection and verification. 
 
Statistical Analysis. 
Descriptive statistics will be used to summarize and determine the sample characteristics and distribution of 
patients presented and diagnosed with COVID-19 infection. The normally distributed data and results will be 
reported with mean and standard deviation (SD) with corresponding 95% confidence interval (CI); the remaining 
results will be reported with median and inter-quartile range (IQR). Categorical data will be summarized using 
frequencies and proportions. Associations between two or more qualitative will be assessed using Chi-square (χ2) 
test or Fisher Exact test as appropriate. Quantitative data between the two independent groups will be analyzed 
using unpaired t test. Data with a non-normal distribution will be compared using the Wilcoxon rank-sum test 
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and presented as the median and interquartile range. 
Baseline data including demographic, history of illness, clinical and laboratory variables will be included in 
the logistic regression analyses to assess their associations with COVID-19 severity and mortality. Univariate 
and multivariate logistic regression analyses will be carried out to determine the risk factors (using main 
exposure variables serum albumin level and nutritional parameters stated above) for severe COVID-19 mortality 
and results will be presented and reported in odds ratio (OR) and associated 95% CI.. The optimal cutoff of the 
albumin level and nutritional parameters for predicting COVID-19 severity and mortality will be determined by 
analyses of the receiver operating characteristic (ROC) curve. Relationship between two quantitative variables 
will be examined using Pearson’s or Spearman’s correlation coefficients. All P values presented will be two-
tailed, and P values <0.05 will be considered as statistically significant. All Statistical analyses will be done 
using statistical packages SPSS 27.0 (SPSS Inc. Chicago, IL) software. The Statistical Package for the Social 
Sciences (SPSS 27.0 software) was used to analyses the data. Descriptive statistics was obtained using means 
(SD) and percentages. Several indicators were examined to determine the frequency and percentage of patients 
who have serum albumin level and nutritional parameters deficiencies related to mortality rate, for icu-covid-19 
patients at Hazem Mebaireek general hospital (HMGH), state of Qatar (MARCH TO SEPTEMBER / 2020). P 
values less than 0.05 was considered as significant with confidence level 95%. 
 
Results: 
The collected data from medical record were reviewed from 1st of April to end of September 2020 of patients 
who were diagnosed as COVID-19 positive & admitted in ICU-HMGH, which included all patients in this 
period. Total of 1059, among them 78 (7.4%) patients were females and 981(92.6%) of them were males. 
Comparing with nationality 93(8.78%) patients were Qatari and 966(91.21%) were non-Qatari, 951 (89.8%) was 
survived & 108 (10.2%) were non survived, furthermore 12 (11.1 %) patient from the non-survived patients were 
Qatari & 96 (88.9 %) were non-Qatari. 
In the results it found that 136 (12.8%) of patients had Hyperlipidemia, 75 (7.1%) had obesity, 577 (54.5%) 
with diabetes, 513 (48.41%) with hypertension, & 129 (12.2%) had chronic lung disease, table (1). 
Table (1):  Results of Co-Morbidity with COVID-19 positive patients who were admitted to ICU 
Co-Morbidity Yes No 
Hyperlipidemia 136 12.80% 923 87.20% 
Obesity 75 7.10% 984 92.90% 
Diabetes 577 54.50% 482 45.55 
Hypertension 513 48.40% 549 51.60% 
Chronic lung disease 129 12.20% 930 87.80% 
Results of nutritional parameters with COVID-19 positive patients who were admitted to ICU. 
 
Table (2): Vitamin D value on admission and before discharge for non-survived patients. 
Reference value  On admission before Discharge 
Below 30 ng/mL 5 5 
Above 30 ng/mL 20 16 
No result 83 87 
Table (2) shows that on admission 5 patients had vitamin D value below 30 ng/mL, 20 had above 30 ng/mL and 
83 patients had no results. before discharge 5 patients had vitamin D value below 30 ng/mL, 16 had above 30 
ng/mL and 87 patients had no results. 
 
Table (3): Vitamin B12 value on admission and before discharge for non-survived patients. 
Reference value  On admission before Discharge 
Below 133 p mol/L 0 0 
Above 133 p mol/L 12 12 
No result 96 96 
Table (3 )shows the Vitamin B12 value among the patients during admission and before discharge, no patient 
reported below 133 ng/mL, 12 patients had above 133 ng/mL of Vitamin B12 value on admission and before 
discharge, 96 patients had no result of Vitamin B12 value on admission and before discharge. 
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Table (4): Cholesterol value on admission and before discharge for non-survived patients. 
Reference value  On Admission Before Discharge 
Normal < 5.2 mmol/L 30 31 
Borderline high 5.2 - 6.2 mmol/L 2 2 
High value > 6.2 mmol/L 3 2 
No result 73 73 
Table (4) cholesterol value on admission and before discharge, 30 patients had below 5.2 mmol/L on admission 
and 31 patients before discharge. 2 patients reported borderline high of cholesterol level 5.2 - 6.2 mmol/L on 
admission and before discharge. 3 patients had high cholesterol level > 6.2 mmol/L on admission and 2 patients 
had high level before discharge.73 patients had no results. 
 
Table (5): HbA1c% value on admission and before discharge for non-survived patients. 
Reference Value On Admission Before Discharge 
Normal low < 4.8 % 0 0 
Normal high (4.8-6) % 11 11 
High value > 6% 45 45 
No result 52 52 
Table (5) shows that 0 patient reported the HbA1c value below 4.8%, 11 patients had normal high level of 
HbA1c (4.8-6) % on admission and before discharge, 45 patients had high level on admission and before 
discharge, 52 patients had no results. 
 
Table (6): BMI value on admission and before discharge for non-survived patients. 
Reference value Admission Discharge 
Underweight value <18.5 kg/m2 2 2 
Normal weight 18.5 -25 kg/m2 41 41 
Overweight 25-30 kg/m2  33 34 
Obese > 30 kg/m2 32 31 
Regarding BMI value the above table shows that 2 patients are underweight < 18.5 kg/m2 on admission and 
before discharge, 41 patients had normal BMI on admission & discharge, 33 patients are overweight on 
admission and 34 patient are overweight before discharge, and 32 patient are Obese > 30 kg/m2 on admission & 
31 patient are Obese > 30 kg/m2 before discharge. 
 
Table (7): Albumin value on admission and before discharge for all ICU-COVID +ve patients:  
Reference value On admission Before discharge 
Below 35 gm/L 581 768 
Above 35 gm/L 478 291 
Table (7) shows that 581 patients had albumin value below 35 gm/L on admission and 768 had below 35 gm/L 
before discharge. 478 patients had albumin level above 35 gm/L on admission and 291 patients had above 35 
gm/L albumin level before discharge. 
 
Table 8: Albumin value on admission and before discharge for non-survived patients. 
Reference value  On admission Before discharge 
Below 35 gm/L 80 (74.1%) 108 (100%) 
35 gm/L and Above 28 (25.9%) 0 
Table (8) shows that among non-survived patients who 108 (100%) of them had low serum albumin levels 
before death and 80 (74.1%) of them had below 35 gm/L albumin and 28 (25.9%) patients had 35 gm/L and 
above albumin levels on admission.  
 
Discussion. 
On 30 January 2020, World Health Organization (WHO) announced that the COVID-19 outbreak was a Public 
Health Emergency of International Concern. As of 11 March, the WHO announced that COVID-19 is now 
declared as a pandemic. As of 31 March 2020, a total of 750,890 confirmed cases of COVID-19 have been 
reported in >200 countries. To date, most cases were reported in China, with some cases developing in other 
countries. The number of cases in China declined, during February 2020, while the number of cases reported 
outside China increased and the number of countries reporting cases increased. Several countries have 
demonstrated that COVID-19 transmission from one person to another can be slowed or stopped. Protection 
actions which followed in Qatar have saved lives and have provided the rest of the world with more time to 
prepare for the arrival of COVID-1918. 
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In 2019, the Ministry of Public Health worked with responsible persons to produced “Qatar National 
Preparedness and Response Plan for Communicable Diseases” to face the pandemic. the plan was 
comprehensive that embodies capacity building and readiness to manage potential outbreaks. The purpose of 
developing the response plan was to manage the threats of communicable diseases in terms of preventing their 
occurrence, mitigating the risks, controlling, and containing the disease that occurred. It also covers the 
management of different outbreak and pandemic scenarios. The plan was developed adapting the WHO’s 
recommended Pandemic Influenza Risk Management Guide 2013 to support the harmonization of national and 
international pandemic preparedness and response19.  
Despite these initial difficulties, death rates are low. The known mortality rate in Qatar based on 
government figures and those from Johns Hopkins University is 0.3%, and mirrors those of smaller neighboring 
Gulf countries, which range from 0.1% (Kuwait) to Bahrain (0.6%). Saudi Arabia’s death rate, by contrast, is 
around 1.4%. This places Qatar well below the World Health Organization’s 3rd March estimate of a 3.4% global 
death rate. Although such figures are highly formative, most Gulf countries have demographic characteristics 
with a relatively small elderly population19. 
The relationship between hypoalbuminemia with reduced survival may have several explanations, first 
acting as an anti-inflammatory and antioxidant protein, albumin may protect against the cytokine storm and the 
ensuing organ failure. It is of interest the inverse relationship between serum albumin and troponin levels, 
suggesting that albumin might exert some protection against myocardial injury. Second, albumin encompasses 
anticoagulant properties and inhibits oxidative stress- related clotting and platelet activation. Therefore the 
negative impact of hypoalbuminemia on clotting activation may be another factor accounting for poor survival 
this is suggested at least, in part by our findings of an inverse association between albumin and D-dimer levels, it 
is the marker of thrombotic risk and increased mortality in COVID-19. The study observation leads to the 
hypothesis that serum albumin analysis may be used to identify patients at higher risk of death in COVID-19 
patients17. 
Our study results shows that total of 1059 COV-D-19 positive patient, among them 78 (7.4%) patients were 
females and 981(92.6%) of them were males comparing to the study conducted by Mohitosh Biswas, COVID-19 
male patients were associated with significantly increased risk of mortality compared to females 13. 
Present study also shows that among 1059 patients admitted in ICU in HMGH, 951(89.8%) patients 
survived and 108 (10.2%) patients died. Among 108 patients died, 96 (88.9%) were males and 12 (11.1%) were 
females, which is corelated to the study conducted by Mohitosh Biswas13, with result that COVID-19 male 
patients were associated with significantly increased risk of mortality compared to females. 
In our study among 1059 patients, 581 (54.9%) patients had albumin level below 35 gm/L on admission and 
768 (72.5%) had below 35 gm/L before discharge. 478 (45.1%) patients had albumin level above 35 gm/L on 
admission and 291 (27.5%) patients had above 35 gm/L albumin level before discharge. Among the 108 patients 
died, 28 (25.9%) patients had serum albumin value above 35 gm/L on admission and 80 (74.1%) patients had 
below 35 gm/L of serum albumin level on admission. 
All the patients 108 (100%) had low serum albumin level of less than 35 gm/L before death which is 
corelated to the study conducted by Dr. Ananya Mandal regarding the low albumin levels could predict poor 
outcome in COVId-19 patients. In this study of 48 patients, 21 were admitted into intensive care (ICU), and 27 
were not. The symptoms prior to hospitalization included fever (in all patients), cough (in 85 percent patients), 
difficulty in breathing (in 76 percent patients), diarrhea (42 percent patients, and weakness (21 percent).The 
main reason for hospitalization among the patients was low blood oxygen (low SpO2 below 90 percent) and the 
presence of pneumonia in both lungs. Pneumonia in both lungs was seen in 94 percent of cases. Lower levels of 
blood albumin were significantly associated with poorer outcome and a longer stay in the hospital. The risk of 
death was also higher among those with lower levels of albumin in their blood15. 
With this study the same study conducted by Muhammad Aziz, Rawish Fatima about the association of low 
serum albumin level with severe COVID-19 patients, which demonstrate the association of hypoalbuminemia 
and severe COVID-19. A low albumin level can potentially lead to early recognition of severe disease and assist 
clinicians in making informed decision for their patients16. 
A retrospective cohort study conducted by Roberto de la Rica, Marcio Borges, María Aranda, July 15, 2020 
Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain, the 
objective of the study is to describe the clinical characteristics and epidemiological features of severe (non-ICU) 
and critically patients (ICU) with COVID-19 at triage, prior hospitalization. 48 patients (27 non-ICU and 21 ICU) 
resident in Mallorca, Spain (mean age, 66 years, (range, 33-88 years); 67% males) with positive SARS-CoV-2 
infection were analyzed. Lower albumin levels were associated with poor prognosis measured as longer hospital 
length and mortality. The study concluded that critically ill patients with COVID-19 present lymphopenia, 
hypoalbuminemia as well high levels of inflammation. Lower levels of albumin were associated with poorer 
outcomes in COVID-19 patients. Albumin might be of importance because of its association with disease 
severity in patients infected with SARS-CoV-217. 
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Another study shows that Hypoalbuminemia predicts the outcome of COVID-19 independent of age and 
co-morbidity, conducted by Jiaofeng Huang 1, Aiguo Cheng reveals that Lower albumin level is seen in severe 
COVID-19 and is not parallel to the changes in alanine aminotransferase and aspartate aminotransferase levels. 
The study aimed to explore the impact of hypoalbuminemia in COVID-19. This retrospective cohort study 
included adult patients with confirmed COVID-19. The relationship between hypoalbuminemia and death was 
studied using binary logistic analysis. A total of 299 adult patients were included, 160 (53.5%) were males and 
the average age was 53.4 ± 16.7 years. Approximately one-third of the patients had comorbidities20. 
Xiaoyue Wang, Yan Xu study shows that the patients with mild and severe COVID-19 showed significant 
differences in terms of, pretreatment C-reactive protein-to-albumin ratio (CAR) (P < 0.05). The severity of 
COVID-19 was correlated positively with the comorbidity of CAR (P < 0.05)21 
From our study reports, in overall cases 577(54.50%) patients had diabetes, and of the 108 expired patients 
69 (63.9)% had diabetes, which is similar to the study conducted by Aidin Rawshani shows that among persons 
with diabetes of either type COVID-19, related mortality is associated with older age, male sex, socioeconomic 
deprivation, non-white ethnicity, established cardiovascular disease, and impaired renal function, glycemic 
control and with both obesity and underweight .14 
Comorbidity may also relate to reduced immune function. For example, in diabetic patients, natural immune 
function reduced substantially which may restrict the body to produce respective antibody against any infection, 
Effects of various comorbidities such as hypertension, diabetes mellitus, respiratory disease, cardiovascular 
disease, cerebrovascular disease, kidney disease, liver disease, and cancer were compared between survivors and 
non-survivors with these comorbidities. All these comorbid conditions except liver disease were significantly 
higher in non-survivors compared to survivors 13. 
Our study shows that on admission 5 patients had vitamin D below 30 ng/ml, 20 patients had above 30 
ng/ml and 83 patients had no results. Before death 5 patients had vitamin D below 30 ng/ml, 16 patients had 
above 30 ng/ml and 87 patients had no results. Vitamin B12 among the patients during admission and discharge, 
no patient reported below 133 p mol/L, 12 patients had above 133 p mol/L of Vitamin B12 on admission and 
discharge, 96 patients had no result of Vitamin B12 on admission and discharge. Nutrients play a vital role in the 
defense against infectious diseases and the regulation of inflammation; however, little is known with regards to 
COVID-19. 
Obesity is a common chronic disease which affect other chronic diseases, and increases the risk of severe 
illness of COVID-1923, according to CDC the obesity of adult persons with excess weight are at even greater risk 
during the COVID-19 pandemic; our study shows that from the 1059 cases 75 (7.1 %) were obese, of the 108 
expired patients 31 (28.7 %) were obese. 
Jae HyoungIm’s study measured concentrations of vitamins B1, B6, B12, folate, vitamin D (25-
hydroxyvitamin D), selenium, and zinc in 50 patients with COVID-19. Vitamin D deficiency was shown in 76% 
of patients and selenium deficiency in 42%. There was a significant difference compared to a control group of 
150 people (vitamin D deficiency 43.3%). Among 12 patients with respiratory distress, 11 (91.7%) had one or 
more nutrient deficiency20. 
Conclusion 
In Qatar there were adequate Implementation of interventions, protections & management to face COVID-
19 prevention. in our study, male patients & hypoalbuminemia were significantly risk of mortality associated 
with COVID-19. Also, this study makes inquiries about the nutritional parameters’ status in patients with 
COVID-19 and with the disease severity. 
 
Recommendation 
• Given Therapeutic management of albumin infusion for COVID-19 patients can decrease the mortality 
rate.  
• To make blood investigation for the nutritional parameters for all patient with COVID -19, & to follow 
the laboratory blood result. 
• Further research is needed to evaluate the impact of nutritional deficiencies in patient with COVID-19. 
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